Author Details
Filipiak, Krzysztof J.
-
Vol 15, No 5 (2011) - Komentarz
ACE inhibitors or sartans — which are better?
Details PDF (Polish) -
Vol 16, No 1 (2012) - REVIEV
Beta-adrenolityk z antagonistą kanału wapniowego jako nowy lek złożony w terapii hipotensyjnej — stanowisko ekspertów
Abstract PDF (Polish) -
Vol 14, No 1 (2010) - Komentarz
KYOTO HEART Study - the next piece of evidence for beneficial stroke prevention activity of angiotensin receptor blockers
Details PDF (Polish) -
Vol 13, No 6 (2009) - Artykuły redakcyjne
The role of fixed-dose combinations in the treatment of hypertension - expert opinion
Details PDF (Polish) -
Vol 13, No 5 (2009) - REVIEV
Treatment of hypertension in patients with concomitant benign prostatic hyperplasia
Abstract PDF (Polish) -
Vol 13, No 1 (2009) - Artykuły redakcyjne
Consensus on the role of AT1 receptor antagonists and angiotensin convertase inhibitors in the treatment of hypertension and its cardiovascular complications
Details PDF (Polish) -
Vol 12, No 5 (2008) - Badania kliniczne. Co nowego w hipertensjologii?
The TRANSCEND study - what every cardiologist, hypertensiologist and internist should know about it
Details PDF (Polish) -
Vol 12, No 2 (2008) - Badania kliniczne
The ONTARGET study results - implications for cardiologists
Details PDF (Polish) -
Vol 11, No 6 (2007) - Artykuły redakcyjne
UMPIRE study - the next episode of the war between sartans and angiotensin converting enzyme inhibitors - commentary
Details PDF (Polish) -
Vol 11, No 4 (2007) - Badania kliniczne
ONTARGET/TRANSCEND/PRoFESS - trzy okręty flagowe telmisartanu - komentarz
Details PDF (Polish) -
Vol 11, No 1 (2007) - Badania kliniczne
The DREAM Trial - what are the conclusions for a physician?
Details PDF (Polish) -
Vol 9, No 2 (2005) - Badania kliniczne. Co nowego w hipertensjologii?
Nebivolol - the fourth beta-blocker in heart failure treatment?
Details PDF (Polish) -
Vol 16, No 4 (2012) - REVIEV
Lerkanidipina w leczeniu nadciśnienia tętniczego i jego powikłań sercowo-naczyniowych
Abstract PDF (Polish) -
Vol 16, No 6 (2012) - Prace oryginalne
The optimal choice of combination therapy with beta-blockers and calcium channel antagonists in everyday practice of hypertensive patients with concomitant ischemic heart disease — findings from BETAMLO Registry
Abstract PDF (Polish) -
Vol 17, No 1 (2013) - Artykuły redakcyjne
Combination therapy in the management of hypertension — current problem in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy
Details PDF (Polish) -
Vol 21, No 1 (2017) - Editorial
Hyperuricemia and its treatment in patients with a high cardio-vascular risk — experts opinion
Details PDF